BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 17671423)

  • 1. Hypoxic suppression of the cell cycle gene CDC25A in tumor cells.
    Hammer S; To KK; Yoo YG; Koshiji M; Huang LE
    Cell Cycle; 2007 Aug; 6(15):1919-26. PubMed ID: 17671423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control.
    Demidova AR; Aau MY; Zhuang L; Yu Q
    J Biol Chem; 2009 Feb; 284(7):4132-9. PubMed ID: 19060337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc.
    Koshiji M; Kageyama Y; Pete EA; Horikawa I; Barrett JC; Huang LE
    EMBO J; 2004 May; 23(9):1949-56. PubMed ID: 15071503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrot and stick: HIF-alpha engages c-Myc in hypoxic adaptation.
    Huang LE
    Cell Death Differ; 2008 Apr; 15(4):672-7. PubMed ID: 18188166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1α, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation.
    Long Y; Tsai WB; Chang JT; Estecio M; Wangpaichitr M; Savaraj N; Feun LG; Chen HH; Kuo MT
    Oncotarget; 2016 Dec; 7(50):82658-82670. PubMed ID: 27765932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YC-1 induces S cell cycle arrest and apoptosis by activating checkpoint kinases.
    Yeo EJ; Ryu JH; Chun YS; Cho YS; Jang IJ; Cho H; Kim J; Kim MS; Park JW
    Cancer Res; 2006 Jun; 66(12):6345-52. PubMed ID: 16778212
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Canales J; Valenzuela M; Bravo J; Cerda-Opazo P; Jorquera C; Toledo H; Bravo D; Quest AF
    Front Cell Infect Microbiol; 2017; 7():92. PubMed ID: 28401064
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia.
    Goda N; Ryan HE; Khadivi B; McNulty W; Rickert RC; Johnson RS
    Mol Cell Biol; 2003 Jan; 23(1):359-69. PubMed ID: 12482987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATR controls cellular adaptation to hypoxia through positive regulation of hypoxia-inducible factor 1 (HIF-1) expression.
    Fallone F; Britton S; Nieto L; Salles B; Muller C
    Oncogene; 2013 Sep; 32(37):4387-96. PubMed ID: 23085754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.
    Laughner E; Taghavi P; Chiles K; Mahon PC; Semenza GL
    Mol Cell Biol; 2001 Jun; 21(12):3995-4004. PubMed ID: 11359907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression.
    Koshiji M; To KK; Hammer S; Kumamoto K; Harris AL; Modrich P; Huang LE
    Mol Cell; 2005 Mar; 17(6):793-803. PubMed ID: 15780936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest.
    Nguyen DX; Westbrook TF; McCance DJ
    J Virol; 2002 Jan; 76(2):619-32. PubMed ID: 11752153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF1-regulated ATRIP expression is required for hypoxia induced ATR activation.
    Ding G; Liu HD; Liang HX; Ni RF; Ding ZY; Ni GY; Hua HW; Xu WG
    FEBS Lett; 2013 Apr; 587(7):930-5. PubMed ID: 23454212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic balancing of the dual nature of HIF-1alpha for cell survival.
    Koshiji M; Huang LE
    Cell Cycle; 2004 Jul; 3(7):853-4. PubMed ID: 15190211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF-1α confers aggressive malignant traits on human tumor cells independent of its canonical transcriptional function.
    Yoo YG; Christensen J; Huang LE
    Cancer Res; 2011 Feb; 71(4):1244-52. PubMed ID: 21303984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 downregulates expression of the G1/S cell cycle phosphatase Cdc25A.
    Rother K; Kirschner R; Sänger K; Böhlig L; Mössner J; Engeland K
    Oncogene; 2007 Mar; 26(13):1949-53. PubMed ID: 17001315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. eIF2{alpha} Kinase PKR modulates the hypoxic response by Stat3-dependent transcriptional suppression of HIF-1{alpha}.
    Papadakis AI; Paraskeva E; Peidis P; Muaddi H; Li S; Raptis L; Pantopoulos K; Simos G; Koromilas AE
    Cancer Res; 2010 Oct; 70(20):7820-9. PubMed ID: 20924113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of c-myc degradation by nickel compounds and hypoxia.
    Li Q; Kluz T; Sun H; Costa M
    PLoS One; 2009 Dec; 4(12):e8531. PubMed ID: 20046830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha.
    Nardinocchi L; Puca R; Sacchi A; Rechavi G; Givol D; D'Orazi G
    PLoS One; 2009 Aug; 4(8):e6819. PubMed ID: 19714248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
    Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.